U.S. flag

An official website of the United States government

NM_198253.3(TERT):c.2591T>C (p.Leu864Pro) AND multiple conditions

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 7, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002533689.10

Allele description [Variation Report for NM_198253.3(TERT):c.2591T>C (p.Leu864Pro)]

NM_198253.3(TERT):c.2591T>C (p.Leu864Pro)

Gene:
TERT:telomerase reverse transcriptase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5p15.33
Genomic location:
Preferred name:
NM_198253.3(TERT):c.2591T>C (p.Leu864Pro)
HGVS:
  • NC_000005.10:g.1266527A>G
  • NG_009265.1:g.33521T>C
  • NM_001193376.3:c.2591T>C
  • NM_198253.3:c.2591T>CMANE SELECT
  • NP_001180305.1:p.Leu864Pro
  • NP_937983.2:p.Leu864Pro
  • NP_937983.2:p.Leu864Pro
  • LRG_343t1:c.2591T>C
  • LRG_343:g.33521T>C
  • LRG_343p1:p.Leu864Pro
  • NC_000005.9:g.1266642A>G
  • NM_198253.2:c.2591T>C
  • NR_149162.3:n.2488T>C
  • NR_149163.3:n.2452T>C
Protein change:
L864P
Links:
dbSNP: rs1561194110
NCBI 1000 Genomes Browser:
rs1561194110
Molecular consequence:
  • NM_001193376.3:c.2591T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198253.3:c.2591T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_149162.3:n.2488T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_149163.3:n.2452T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Dyskeratosis congenita, autosomal dominant 2
Identifiers:
MONDO: MONDO:0013521; MedGen: C3151443; OMIM: 613989
Name:
Idiopathic Pulmonary Fibrosis
Synonyms:
Idiopathic fibrosing alveolitis, chronic form
Identifiers:
MeSH: D054990; MedGen: C1800706

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000832473Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Jun 7, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Danazol Treatment for Telomere Diseases.

Townsley DM, Dumitriu B, Liu D, Biancotto A, Weinstein B, Chen C, Hardy N, Mihalek AD, Lingala S, Kim YJ, Yao J, Jones E, Gochuico BR, Heller T, Wu CO, Calado RT, Scheinberg P, Young NS.

N Engl J Med. 2016 May 19;374(20):1922-31. doi: 10.1056/NEJMoa1515319.

PubMed [citation]
PMID:
27192671
PMCID:
PMC4968696

Pathogenic TERT promoter variants in telomere diseases.

Gutierrez-Rodrigues F, Donaires FS, Pinto A, Vicente A, Dillon LW, Clé DV, Santana BA, Pirooznia M, Ibanez MDPF, Townsley DM, Kajigaya S, Hourigan CS, Cooper JN, Calado RT, Young NS.

Genet Med. 2019 Jul;21(7):1594-1602. doi: 10.1038/s41436-018-0385-x. Epub 2018 Dec 7.

PubMed [citation]
PMID:
30523342
PMCID:
PMC6555700
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000832473.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TERT protein function. ClinVar contains an entry for this variant (Variation ID: 580119). This missense change has been observed in individual(s) with clinical features of TERT-related telomere disease (PMID: 27192671, 30523342; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 864 of the TERT protein (p.Leu864Pro).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024